Otros artículos de Marta Martins
1. Martins, M. 2011. Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca(2+) and K(+) Transport to Enhance the Killing of Intracellular Multi-Drug Resistant M. tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB. Recent Pat. Anti-infect. Drug Discov. 6(2):110-117.
2.Martins, M., M. Viveiros, I. Couto, S.S. Costa, T. Pacheco, S. Fanning, J.M. Pagès, L. Amaral. 2011. Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo 25:171-178.
3.Martins, M., M. McCusker, L. Amaral, S. Fanning. 2011. Mechanisms of Antibiotic Resistance in Salmonella: Efflux Pumps, Genetics, Quorum Sensing and Biofilm Formation. Letters in Drug Design & Discovery 8: 114-123.
4.Amaral, L., M. Martins and M. Viveiros. 2011. Thioridazine: Alternative and Potentially Effective Therapy of the XDR-TB Patient. Letters in Drug Design & Discovery 8: 130-132.
5.Karczmarczyk, M., M. Martins, M . McCusker, S. Mattar, L. Amaral, N. Leonard, F. M. Aarestrup and S. Fanning. 2010. Characterization of antimicrobial resistance in Salmonella enterica food and animal isolates from Colombia: identification of a qnrB19-mediated quinolone resistance marker in two novel serovars. FEMS Microbiol Lett. 313:10-19.
6.Viveiros, M., M. Martins, I. Couto, L. Rodrigues, D. Machado, I. Portugal and L. Amaral. 2010. Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections. Expert. Rev. Anti Infect. Ther. 8:465-80.
7. Martins, M., M. Viveiros, I. Couto, and L. Amaral. 2009. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB. Int. J. Tuberc. Lung Dis. 13:569-573.
8.Martins, M., M. Viveiros, J. Ramos, I. Couto, J. Molnar, M. Boeree, and L. Amaral. 2009. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB). Int. J. Antimicrob. Agents 33:479-482.
9. Viveiros, M., M. Martins, I. Couto, L. Rodrigues, G. Spengler, A. Martins, J. E. Kristiansen, J. Molnar and L. Amaral. 2008. New Methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr. Drug Targets. 9:760-778.
10. Martins, M., S. G. Dastidar, S. Fanning, J. E. Kristiansen, J. Molnar, J. M. Pagès, Z. Schelz, G. Spengler, M. Viveiros, and L. Amaral. 2008. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int. J. Antimicrob. Agents 31:198–208.
Para comunicarse con Marta Martins mencionar a SIIC como
referencia:
marta.martins@ucd.ie
Autora invitada
24 de junio, 2011
Descripción aprobada
18 de julio, 2011
Reedición siicsalud
7 de junio, 2021